Skip to content
DarshanTalks Podcast cover art

All episodes

DarshanTalks Podcast, 357 episodes. Page 4 of 4.

#
Title
301

Legal Minute: Clinical Trial Record Retention Disasters

302

Legal Minute: Why is your medicine so expensive?

303

McKinsey’s 2030 vision: A challenge for medical affairs

304

Legal Minute: 3 must-do takeaways for collecting diversity data in clinical trials

305

Legal Minute: Are Brand and Generic Drugs Truly Different?

306

Legal Minute: Who's REALLY Responsible for a Clinical Trial Congruency review?

307

This Drug Ad is FULL of Red Flags (We Expose Them All!)

308

7 ways to challenge FDA’s regulation of LDTs

309

Legal Minute: eBay’s $59 Million Drug-Making Problem

310

Legal Minute: Neuralink is a Game-Changer: 3 Lessons You Can't Afford to Miss

311

Legal Minute: Off-label marketing not ok again?

312

Don't Become the Next Fraud Headline: Lawyer Reveals Compliance Traps

313

Legal Minute: 3 Insider Secrets for a Successful Medical Device Recall

314

Key elements of a successful congruency review for clinical trial agreements

315

Why Private Equity firms are betting big on clinical research sites

316

5 Ways to Legally Share Off-Label Information

317

DOJ's "Get Out of Jail Free" card for pharma and device mergers?

318

Legal Minute: 5 factors to get your digital speaker program approved

319

Legal Minute: Decoding the FDA's prescription drug use related software guidance

320

Congruency Review: The Game Changer

321

Legal Minute: 5 hacks to fast-track your speaker program reviews

322

Selecting your ideal subject recruitment partner

323

Your digital sales team’s success depends on these 5 compliance rules

324

Legal Minute: 3 FTC rules for winning comparative claims

325

The risks and rewards of Clinical Research as a Care Option

326

3 game changing ways the FDA says AI will transform drug development

327

Legal Minute: Comparative claim review by NAD

328

5 foolproof ways to get your digital speaker program approved

329

Legal Minute: Prepare your Cosmetics Company for 2024

330

How to get PRC to approve your ads quickly

331

Legal Minute: 4 Must Do's When Choosing a Predicate Device for Your 510(k)

332

Legal Minute: FDA's Vision for the Future of IT

333

Legal Minute: FTC announces major revamp in 2024 enforcement strategy

334

23andMe data breach: Is your genetic data the next big target for hackers?

335

Ultimate Guide for Clinical Trial Publishing Rights in Large Academic Centers | Istvan Fekete

336

FDA's off-label trap: 7 reasons for uncertainty

337

Legal Minute: 3 ways #pharmacies are fighting high generic drug prices!

338

Pharma Industry Secrets: The Surprising Truth About DEI | Celia Daniels

339

Case Study: Academic Research Center Misconduct

340

Legal Minute: FTC Cracking Down on AI- 3 Must-Know Tips to Stay Compliant

341

Project management as a clinical research game-changer

342

Legal Minute: 5 Must-Do’s for Virginia Tech’s FBRI to combat research fraud

343

Legal Minute: Pharmacy Closing Checklist: 7 Must Do's

344

FDA Approval for LDTs Made Easy

345

Legal Minute: Pharmacist fraudster found guilty

346

AI's Complex Role: Creator, Copycat or Both?

347

FDA warns 8 companies including Walgreens selling unapproved eye products

348

Why the FDA’s plan to use one pagers will fail

349

Supercharge your Marketing Approval Process based on these Concept Review Tips

350

Testosterone parties and unapproved biohacks: Is it worth the risk? #darshantalks

351

Generative AI…confidently spews BS!

352

Testosterone parties and unapproved biohacks: Is it worth the risk? #darshantalks

353

Research Fraudster Banned by the FDA

354

How does CTP regulate tobacco? | Micah Berman

355

60 second reveal: 3 Regulatory authorities that can make or break your pharma or device sale

356

Maximizing FDA meetings: Getting the best out of every encounter | Ashley Preston

357

The role of decentralized trials in the traditional landscape | Isaac Rodriguez- Chavez

358

The Essential Guide to 7 Types of Clinical Trial Agreements